Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Molecular mechanism research of the crude extract of Angong Niuhuang Pill inhibiting GPX4-mediated ferroptosis in mice with juvenile sepsis associated encephalopathy
1Pediatric Intensive Care Unit, First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang Uyghur Autonomous Region, China
2Department of Child Health Care, First Affiliated Hospital of Xinjiang Medical University, 830054 Urumqi, Xinjiang Uyghur Autonomous Region, China
DOI: 10.22514/sv.2025.025 Vol.21,Issue 2,February 2025 pp.97-104
Submitted: 20 June 2024 Accepted: 23 October 2024
Published: 08 February 2025
*Corresponding Author(s): Abulaiti Abuduhaer E-mail: abulati1077@163.com
Background: Sepsis associated encephalopathy (SAE) is a prevalent form of organ dysfunction associated with sepsis. There is no overt central nervous system (CNS) infection accompanying it, yet it carries a significant risk of mortality and can lead to long-lasting neurological complications. The efficacy of Angong Niuhuang Pill (AGNH) in enhancing conditions like cerebral ischemia, cerebral trauma and sepsis has been well-established. Nonetheless, the specific regulatory roles and underlying mechanisms of AGNH in the progression of SAE remain unexplored. Methods: The lipopolysaccharide (LPS) treatment was utilized to construct SAE rat model. Berderson’s neurological examination scoring system was used for scoring. The levels of genes and iron content were examined through enzyme-linked immunosorbent assay (ELISA) or the corresponding commercial kits. The prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT) and fibrinogen (FIB) level were confirmed through the automatic coagulation analyzer. The number and morphology of neurons were evaluated through hematoxylin eosin (HE) staining. The protein expressions were determined through western blot. Results: The increased Berderson never function score mediated by LPS treatment was attenuated after AGNH or Defetoxamine (DFO, ferroptosis inhibitor) treatment, indicating that AGNH improved neurobehavioral function in juvenile SAE mice. Furthermore, AGNH improved inflammation and coagulation parameters in young SAE mice. AGNH promoted neuronal growth and mitigated neuronal damage in juvenile SAE mice. Additionally, AGNH inhibited ferroptosis and reduced oxidative stress in young SAE mice. Lastly, it was demonstrated that AGNH promoted nuclear factor erythroid 2-related factor 2 (Nrf2)/glutathione peroxidase 4 (GPX4) signaling pathway through up-regulating the Nrf2 and GPX4 protein expressions. Conclusions: This study revealed a novel finding that AGNH has the ability to inhibit GPX4-induced ferroptosis in juvenile SAE mice by modulating the Nrf2/GPX4 signaling pathway. This breakthrough implies that AGNH has promising prospects as a therapeutic agent for SAE.
AGNH; Ferroptosis; SAE; Nrf2/GPX4 pathway
Adilijiang Kari,Zhihua Ma,Zhayidan Aili,Gulijianati Abulakemu,Nadire Hairula,Abulaiti Abuduhaer. Molecular mechanism research of the crude extract of Angong Niuhuang Pill inhibiting GPX4-mediated ferroptosis in mice with juvenile sepsis associated encephalopathy. Signa Vitae. 2025. 21(2);97-104.
[1] Rello J, Valenzuela-Sánchez F, Ruiz-Rodriguez M, Moyano S. Sepsis: a review of advances in management. Advances in Therapy. 2017; 34: 2393–2411.
[2] Li X, Wang J. Recent application of metabolomics in the diagnosis, pathogenesis, treatment, and prognosis of sepsis. Signa Vitae. 2023; 19: 15–22.
[3] Pool R, Gomez H, Kellum JA. Mechanisms of organ dysfunction in sepsis. Critical Care Clinics. 2018; 34: 63–80.
[4] Gao Q, Hernandes MS. Hernandes, sepsis-associated encephalopathy and blood-brain barrier dysfunction. Inflammation. 2021; 44: 2143–2150.
[5] Chung HY, Wickel J, Brunkhorst FM, Geis C. Sepsis-associated encephalopathy: from delirium to dementia? Journal of Clinical Medicine. 2020; 9: 703.
[6] Mein N, von Stackelberg N, Wickel J, Geis C, Chung HY. Low-dose PLX5622 treatment prevents neuroinflammatory and neurocognitive sequelae after sepsis. Journal of Neuroinflammation. 2023; 20: 289.
[7] Guo Y, Yan S, Xu L, Zhu G, Yu X, Tong X. Use of angong niuhuang in treating central nervous system diseases and related research. Evidence-Based Complementary and Alternative Medicine. 2014; 2014: 346918.
[8] Liu H, Yan Y, Pang P, Mao J, Hu X, Li D, et al. Angong Niuhuang Pill as adjuvant therapy for treating acute cerebral infarction and intracerebral hemorrhage: a meta-analysis of randomized controlled trials. Journal of Ethnopharmacology. 2019; 237: 307–313.
[9] Fan Q, Liu Y, Rao J, Zhang Z, Xiao W, Zhu T, et al. Anti-atherosclerosis effect of Angong Niuhuang Pill via regulating Th17/Treg immune balance and inhibiting chronic inflammatory on ApoE-/- mice model of early and mid-term atherosclerosis. Frontiers in Pharmacology. 2019; 10: 1584.
[10] Li S, Hou J, Wang Q, Liu M, Xu X, Yang H, et al. Angong niuhuang wan attenuates LPS-induced acute lung injury by inhibiting PIK3CG/p65/MMP9 signaling in mice based on proteomics. Heliyon. 2023; 9: e20149.
[11] Lv L, Zheng J, Zhang Y, Chen B, Yan F, Qin X, et al. Respiratory nursing care with Angong Niuhuang pill for patients with chronic obstructive pulmonary disease following cardiac surgery. Japan Journal of Nursing Science. 2021; 18: e12344.
[12] Zhang H, Hui X, Wang Y, Wang Y, Lu X. Angong Niuhuang Pill ameliorates cerebral ischemia/reperfusion injury in mice partly by restoring gut microbiota dysbiosis. Frontiers in Pharmacology. 2022; 13: 1001422.
[13] Bai X, Zheng E, Tong L, Liu Y, Li X, Yang H, et al. Angong Niuhuang Wan inhibit ferroptosis on ischemic and hemorrhagic stroke by activating PPARγ/AKT/GPX4 pathway. Journal of Ethnopharmacology. 2023; 321: 117438.
[14] Tsoi B, Chen X, Gao C, Wang S, Yuen SC, Yang D, et al. Neuroprotective effects and hepatorenal toxicity of Angong Niuhuang wan against ischemia-reperfusion brain injury in rats. Frontiers in Pharmacology. 2019; 10: 593.
[15] Ge C, Chen W, Zhang L, Ai Y, Zou Y, Peng Q. Chemogenetic activation of the HPC-mPFC pathway improves cognitive dysfunction in lipopolysaccharide-induced brain injury. Theranostics. 2023; 13: 2946–2961.
[16] Gao R, Tang YH, Tong JH, Yang JJ, Ji MH, Zhu SH. Systemic lipopolysaccharide administration-induced cognitive impairments are reversed by erythropoietin treatment in mice. Inflammation. 2015; 38: 1949–1958.
[17] Ding H, Li Y, Chen S, Wen Y, Zhang S, Luo E, et al. Fisetin ameliorates cognitive impairment by activating mitophagy and suppressing neuroinflammation in rats with sepsis-associated encephalopathy. CNS Neuroscience & Therapeutics. 2022; 28: 247–258.
[18] Tian M, Qingzhen L, Zhiyang Y, Chunlong C, Jiao D, Zhang L, et al. Attractylone attenuates sepsis-associated encephalopathy and cognitive dysfunction by inhibiting microglial activation and neuroinflammation. Journal of Cellular Biochemistry. 2019; 120: 7101–7108.
[19] Yin Y, Lv G, Zhang W, Yuan J, Yang Y, Wang Y, et al. Resveratrol glycoside mediates microglial endoplasmic reticulum stress to mitigate LPS-induced sepsis-associated cognitive dysfunction. Behavioural Brain Research. 2023; 443: 114326.
[20] Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nature Reviews Molecular Cell Biology. 2021; 22: 266–282.
[21] Yao H, Wang Y, Zhou W, Xu C, Ge X, Zhu JD. Chac1 silencing mitigates hemorrhagic shock-induced intestinal injury by inhibiting oxidative stress and ferroptosis. Signa Vitae. 2023; 19: 184–193.
[22] Guan JJ, Pan ZM, Zhao GA. Identification of a 6-gene signature associated with ferroptosis for predicting the prognosis in prostate cancer. Journal of Men’s Health. 2023; 19: 58–68.
[23] Wei XB, Jiang WQ, Zeng JH, Huang LQ, Ding HG, Jing YW, et al. Exosome-derived lncRNA NEAT1 exacerbates sepsis-associated encephalopathy by promoting ferroptosis through regulating miR-9-5p/TFRC and GOT1 axis. Molecular Neurobiology. 2022; 59: 1954–1969.
[24] Chu J, Jiang Y, Zhou W, Zhang J, Li H, Yu Y, et al. Acetaminophen alleviates ferroptosis in mice with sepsis-associated encephalopathy via the GPX4 pathway. Human & Experimental Toxicology. 2022; 41: 9603271221133547.
[25] Du L, Wu Y, Jia Q, Li J, Li Y, Ma H, et al. Autophagy suppresses ferroptosis by degrading TFR1 to alleviate cognitive dysfunction in mice with SAE. Cellular and Molecular Neurobiology. 2023; 43: 3605–3622.
[26] Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biology. 2019; 23: 101107.
[27] Capelletti MM, Manceau H, Puy H, Peoc’h K. Ferroptosis in liver diseases: an overview. International Journal of Molecular Sciences. 2020; 21: 4908.
[28] Xu C, Ni S, Xu N, Yin G, Yu Y, Zhou B, et al. Theaflavin-3,3′-digallate inhibits erastin-induced chondrocytes ferroptosis via the Nrf2/GPX4 signaling pathway in osteoarthritis. Oxidative Medicine and Cellular Longevity. 2022; 2022: 3531995.
[29] Wang Y, Yan S, Liu X, Deng F, Wang P, Yang L, et al. PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway. Cell Death & Differentiation. 2022; 29: 1982–1995.
[30] Ge MH, Tian H, Mao L, Li DY, Lin JQ, Hu HS, et al. Zinc attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury by activating Nrf2/GPX4 defense pathway. CNS Neuroscience & Therapeutics. 2021; 27: 1023–1040.
[31] Liao T, Xu X, Ye X, Yan J. DJ-1 upregulates the Nrf2/GPX4 signal pathway to inhibit trophoblast ferroptosis in the pathogenesis of preeclampsia. Scientific Reports. 2022; 12: 2934.
[32] Wang J, Zhu Q, Wang Y, Peng J, Shao L, Li X. Irisin protects against sepsis-associated encephalopathy by suppressing ferroptosis via activation of the Nrf2/GPX4 signal axis. Free Radical Biology and Medicine. 2022; 187: 171–184.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 1.3 (2023) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.
Top